These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 31695439)
1. Single-Use Autoinjector Functionality And Reliability For At-Home Administration Of Benralizumab For Patients With Severe Asthma: GRECO Trial Results. Ferguson GT; Cole J; Aurivillius M; Roussel P; Barker P; Martin UJ; J Asthma Allergy; 2019; 12():363-373. PubMed ID: 31695439 [TBL] [Abstract][Full Text] [Related]
2. Comparison of autoinjector with accessorized prefilled syringe for benralizumab pharmacokinetic exposure: AMES trial results. Martin UJ; Fuhr R; Forte P; Barker P; Axley MJ; Aurivillius M; Yan L; Roskos L J Asthma; 2021 Jan; 58(1):93-101. PubMed ID: 31539289 [TBL] [Abstract][Full Text] [Related]
3. Functionality and Performance of an Accessorized Pre-Filled Syringe and an Autoinjector for At-Home Administration of Tezepelumab in Patients with Severe, Uncontrolled Asthma. Alpizar S; Megally A; Chen C; Raj A; Downie J; Colice G J Asthma Allergy; 2021; 14():381-392. PubMed ID: 33907423 [TBL] [Abstract][Full Text] [Related]
4. Tezepelumab Pharmacokinetics, Safety, and Tolerability After Administration via Vial-and-syringe, Accessorized Prefilled Syringe, or Autoinjector: A Randomized Trial in Healthy Volunteers. Zheng Y; Abuqayyas L; Megally A; Fuhr R; Sałapa K; Downie J; Colice G Clin Ther; 2021 Jan; 43(1):142-155.e5. PubMed ID: 33380362 [TBL] [Abstract][Full Text] [Related]
5. Assessment of an accessorized pre-filled syringe for home-administered benralizumab in severe asthma. Ferguson GT; Mansur AH; Jacobs JS; Hebert J; Clawson C; Tao W; Wu Y; Goldman M J Asthma Allergy; 2018; 11():63-72. PubMed ID: 29670379 [TBL] [Abstract][Full Text] [Related]
6. Reliability, Satisfaction and Effectiveness of Benralizumab Home Self-Administration in Patients with Severe Eosinophilic Asthma in Real-World Practice: The Auto-Benra Study. García-Moguel I; Rosado A; Gómez-Cardeñosa A; Gandolfo-Cano M; Robledo Echarren T; Moro Moro MDM; Reaño Martos MDM; Pineda-Pineda R; Valverde-Monge M; Martin-Arriscado Arroba C; Domínguez-Ortega J; J Asthma Allergy; 2022; 15():623-632. PubMed ID: 35592384 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and tolerability of prefilled syringe and auto-injector presentations of MSB11456: results of a randomized, single-dose study in healthy adults. Tomaszewska-Kiecana M; Dryja A; Ullmann M; Petit-Frere C; Illes A; Dagres C; Monnet J Expert Rev Clin Immunol; 2023 Apr; 19(4):447-455. PubMed ID: 36789991 [TBL] [Abstract][Full Text] [Related]
9. An open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an Avonex® prefilled syringe in multiple sclerosis subjects. Phillips JT; Fox E; Grainger W; Tuccillo D; Liu S; Deykin A BMC Neurol; 2011 Oct; 11():126. PubMed ID: 21999176 [TBL] [Abstract][Full Text] [Related]
10. Summative Usability Evaluation of the SCTE-AI Device: A Novel Prefilled Autoinjector for Subcutaneous Testosterone Administration. Arora S; Moclair B; Murphy K; Jaffe JS; Kaminetsky JC J Sex Med; 2018 Dec; 15(12):1707-1715. PubMed ID: 30393104 [TBL] [Abstract][Full Text] [Related]
11. Usability of mepolizumab single-use prefilled syringe for patient self-administration. Bel EH; I Bernstein D; Bjermer L; Follows R; Bentley JH; Pouliquen I; Bradford E J Asthma; 2020 Jul; 57(7):755-764. PubMed ID: 31017022 [No Abstract] [Full Text] [Related]
12. Comparable Pharmacokinetics, Safety, and Tolerability of Etrolizumab Administered by Prefilled Syringe or Autoinjector in a Randomized Trial in Healthy Volunteers. Zhang W; Tyrrell H; Ding HT; Pulley J; Boruvka A; Erickson R; Abouhossein M; Ravanello R; Tang MT Adv Ther; 2021 May; 38(5):2418-2434. PubMed ID: 33778929 [TBL] [Abstract][Full Text] [Related]
13. Usability of Prefilled Syringe and Autoinjector for SB4 (An Etanercept Biosimilar) in Patients with Rheumatoid Arthritis. Rho YH; Rychlewska-Hańczewska A; Śliwowska B; Kim TH Adv Ther; 2019 Sep; 36(9):2287-2295. PubMed ID: 31372961 [TBL] [Abstract][Full Text] [Related]
14. Comparison between prefilled syringe and autoinjector devices on patient-reported experiences and pharmacokinetics in galcanezumab studies. Stauffer VL; Sides R; Lanteri-Minet M; Kielbasa W; Jin Y; Selzler KJ; Tepper SJ Patient Prefer Adherence; 2018; 12():1785-1795. PubMed ID: 30271122 [TBL] [Abstract][Full Text] [Related]
15. Evidence of bioequivalence and positive patient user handling of a tocilizumab autoinjector. Fettner S; Mela C; Wildenhahn F; Tavanti M; Wells C; Douglass W; Mallalieu NL Expert Opin Drug Deliv; 2019 May; 16(5):551-561. PubMed ID: 31043095 [TBL] [Abstract][Full Text] [Related]
16. Absolute Bioavailability and Pharmacokinetic Comparability of Sirukumab Following Subcutaneous Administration by a Prefilled Syringe or an Autoinjector. Zhuang Y; de Vries DE; Marciniak SJ; Liu H; Zhou H; Davis HM; Leon F; Raible D; Xu Z Clin Pharmacol Drug Dev; 2017 Nov; 6(6):570-576. PubMed ID: 28052588 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of Subcutaneous Itepekimab Injection With an Autoinjector Device and Prefilled Syringe in Healthy Participants. Xu C; Xin K; Kosloski MP; Butler A; Goulaouic H; Nivens MC; Kanamaluru V Clin Pharmacol Drug Dev; 2024 Nov; 13(11):1181-1188. PubMed ID: 39308293 [TBL] [Abstract][Full Text] [Related]
18. Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study. Vermeire S; D'heygere F; Nakad A; Franchimont D; Fontaine F; Louis E; Van Hootegem P; Dewit O; Lambrecht G; Strubbe B; Baert F Patient Prefer Adherence; 2018; 12():1193-1202. PubMed ID: 30013330 [TBL] [Abstract][Full Text] [Related]
19. Usability and safety of SB5 (an adalimumab biosimilar) prefilled syringe and autoinjector in patients with rheumatoid arthritis. Ghil J; Zielińska A; Lee Y Curr Med Res Opin; 2019 Mar; 35(3):497-502. PubMed ID: 30561229 [TBL] [Abstract][Full Text] [Related]
20. Assessment of real-life patient handling experience of AVT02 administered subcutaneously via autoinjector in patients with moderate to severe active rheumatoid arthritis: an open-label, single-arm clinical trial, then an extension phase of AVT02 administered with a prefilled syringe. Damjanov N; Kirvalidze N; Kurashvili N; Berti F; Steiger M; Sobierska J; Guenzi E; Otto H; Sattar A; Haliduola HN; Edwald E; Stroissnig H Expert Opin Biol Ther; 2023; 23(8):781-789. PubMed ID: 36205514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]